- •Alcoholic cardiomyopathy (ACM) is a specific phenotype of the non-ischaemic dilated cardiomyopathy (NI-DCM) spectrum
- •In our multicentre study, we evaluated CMR features of 114 patients (52 patients with ACM, 62 with idiopathic NI-DCM)
- •CMR features of ACM showed a different LGE localization in ACM vs iNI-DCM, with different prognostic impact
Alcoholic cardiomyopathy(ACM) is part of the non-ischaemic dilated cardiomyopathy(NI-DCM) spectrum. Little is known about cardiovascular magnetic resonance(CMR) features in ACM patients. The aim of this study is to describe CMR findings and their prognostic impact in ACM patients.
Consecutive ACM patients evaluated in five referral CMR centres from January 2005 to December 2018 were enrolled. CMR findings and their prognostic value were compared to idiopathic NI-DCM(iNI-DCM) patients. The main outcome was a composite of death/heart transplantation/life-threatening arrhythmias.
Overall 114 patients (52 with ACM and 62 with iNI-DCM) were included. ACM patients were more often males compared to iNI-DCM (90% vs 64%, respectively, p ≤ 0.001) and were characterized by a more pronounced biventricular adverse remodelling than iNI-DCM, i.e. lower LVEF (31 ± 12% vs 38 ± 11% respectively, p = 0.001) and larger left ventricular end-diastolic volume (116 ± 40 ml/m2 vs 67 ± 20 ml/m2 respectively, p < 0.001). Similarly to iNI-DCM, late gadolinium enhancement (LGE), mainly midwall, was present in more than 40% of ACM patients but, conversely, it was not associated with adverse outcome(p = 0.15). LGE localization was prevalently septal (87%) in ACM vs lateral in iNI-DCM(p < 0.05). Over a median follow-up of 42 months [Interquartile Range 24–68], adverse outcomes were similar in both groups(p = 0.67).
ACM represents a specific phenotype of NI-DCM, with severe morpho-functional features at the onset, but similar long-term outcomes compared to iNI-DCM. Despite the presence and pattern of distribution of LGE was comparable, ACM and iNI-DCM showed a different LGE localization, mostly septal in ACM and lateral in iNI-DCM, with different prognostic impact.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to International Journal of Cardiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Genetic etiology for alcohol-induced cardiac toxicity.J. Am. Coll. Cardiol. 2018 May 22; 71 (PMC5957753): 2293-230229773157
- Alcohol and the global burden of disease.Lancet. 2019 Jun 15; 393 (Epub 2019/06/18): 239031204674
- Association between alcohol intake and cardiac remodeling.J. Am. Coll. Cardiol. 2018 Sep 25; 72 (Epub 2018/09/22): 1452-146230236306
- Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.JAMA. 2013 Mar 6; 309 (Epub 2013/03/07): 896-90823462786
- Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.Eur. Heart J. 2016 Jan; 1926792875
- Evolving concepts in dilated cardiomyopathy.Eur. J. Heart Fail. 2018 Feb; 20: 228-23929271570
- Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.Eur. J. Heart Fail. 2014 Mar; 16: 317-32424464640
- Viral presence-guided immunomodulation in lymphocytic myocarditis: an update.Eur. J. Heart Fail. 2020 Jul; 19 (PMC7405140. (Epub 2020/07/20))32683758
- Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy.Eur. J. Heart Fail. 2020 Jul; 22 (Epub 2020/05/27): 1111-112132452075
- Sex differences in the long-term prognosis of dilated cardiomyopathy.Can. J. Cardiol. 2020 Jan; 36 (Epub 2019/09/14): 37-4431515085
- Myocarditis evolving in cardiomyopathy: when genetics and offending causes work together.Eur. Heart J. Suppl. 2019 Mar; 21 (B90-B5) (PMC6439912. (Epub 2019/04/06))30948961
- Regular alcohol consumption is associated with impaired atrial mechanical function in the atrial fibrillation population: a cross-sectional MRI-based study.JACC Clin. Electrophysiol. 2018 Nov; 4 (Epub 2018/11/24): 1451-145930466852
- Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study.Am. Heart J. 1998 May; 135 (Epub 1998/05/20): 833-8379588413
- Alcohol consumption and biological markers for alcoholism in idiopathic dilated cardiomyopathy: a case-controlled study.Alcohol Alcohol. 1992 Jul; 27 (Epub 1992/07/01): 353-3581418109
- Alcohol abstinence in drinkers with atrial fibrillation.N. Engl. J. Med. 2020 Jan 2; 382 (Epub 2020/01/02): 20-2831893513
- Gender differences in the relationship between alcohol consumption and drink problems are largely accounted for by body water.Alcohol Alcohol. 1999 Nov-Dec; 34: 894-90210659726
- From the cover: alcohol inhibition of the enzymatic activity of glyceraldehyde 3-phosphate dehydrogenase impairs cardiac glucose utilization, contributing to alcoholic cardiomyopathy.Toxicol. Sci. 2017 Oct 1; 159 (Epub 2017/10/01): 392-40128962519
- Alcoholic cardiomyopathy : the result of dosage and individual predisposition.Herz. 2016 Sep; 41 (PubMed PMID: 27582365. Pubmed central PMCID: PMC5013142. Epub 2016/09/02. Alkoholische Kardiomyopathie : Eine Folge der Dosis und der individuellen Pradisposition): 484-493
- Oxidative stress and cellular and tissue damage in organogenic outbred mouse embryos after moderate perigestational alcohol intake.Mol. Reprod. Dev. 2017 Oct; 84 (Epub 2017/07/15): 1086-109928708332
- Alcoholic cardiomyopathy: disrupted protein balance and impaired cardiomyocyte contractility.Alcohol. Clin. Exp. Res. 2017 Aug; 41 (PMC5522635. (Epub 2017/04/21)): 1392-140128425109
- The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis.JACC Cardiovasc. Imaging. 2018 Sep; 11: 1274-128429680351
- Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure.Circ. Heart Fail. 2014 May; 7: 448-45624647118
- Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction.Circulation. 2017 May 30; 135 (PMC5444425. (Epub 2017/03/30)): 2106-211528351901
- Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement.JACC Cardiovasc. Imaging. 2019 Aug; 12 (PMC6682609. (Epub 2018/09/17)): 1645-165530219397
- Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes.Circ. Arrhythm. Electrophysiol. 2016 Jul; 9 (PMC4956679. (Epub 2016/07/09))27390211
- Lymphocytic myocarditis: a genetically predisposed disease?.J. Am. Coll. Cardiol. 2020 Jun 23; 75 (Epub 2020/06/20): 3098-310032553263
- Strain-encoded magnetic resonance: a method for the assessment of myocardial deformation.ESC Heart Fail. 2019 Aug; 6 (PMC6676282. (Epub 2019/04/26)): 584-60231021534
Published online: February 02, 2021
Accepted: January 27, 2021
Received in revised form: January 23, 2021
Received: October 30, 2020
© 2021 Elsevier B.V. All rights reserved.